<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-MKUFMF79</identifier><date>2015</date><creator>Hanžel, Jurij</creator><creator>Piletič, Žiga</creator><creator>Šabovič, Mišo</creator><relation>documents/doc/M/URN_NBN_SI_doc-MKUFMF79_001.pdf</relation><relation>documents/doc/M/URN_NBN_SI_doc-MKUFMF79_001.txt</relation><format format_type="issue">1</format><format format_type="volume">66</format><format format_type="type">article</format><format format_type="extent">str. 60-64</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">281555712</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-MKUFMF79</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">cardiovascular disease</subject><subject language_type_id="slv">dejavniki tveganja</subject><subject language_type_id="slv">kardiovaskularne bolezni</subject><subject language_type_id="slv">možganska kap</subject><subject language_type_id="slv">sekundarna preventiva</subject><title>Cardiovascular risk in patients after stroke</title><title>Srčno-žilno tveganje pri bolniku po možganski kapi</title></Record>